Dr Marie-Angélique Sene is Head of Advanced Vaccine Bioprocessing at the Institut Pasteur de Dakar, leading the establishment of a new laboratory responsible for the acquisition and transfer of novel technology. Marie- Angelique began her studies in engineering school studying Material Science, Mechanical Engineering, Quantic Physics, and Relativity while conducting research at one of the French Atomic Energy Commission laboratories. Afterwards she joined the graduate program in Seoul National University to specialize in Micro/Nano engineering while overseeing the Inter-University Semiconductor Research Center’s photolithography equipment Quality Control and offering consulting services for local Korean companies wishing to integrate micro/nanotechnology to their Point-of-Care devices. She worked on projects from various fields such as Agriculture, Green Energies, Semiconductors, Optics, Health among others. Dr Sene now specializes in Vaccines manufacturing and to apply her previously acquired knowledges to this field to contribute in the effort to advance equitable access to vaccines. During her PhD at McGill University in the Kamen Lab, she obtained a patent as main inventor, in collaboration with Sanofi-Pasteur, focusing on the genetic engineering of the Vero cell vaccine production platform providing new possibilities to quickly generate high throughput, globally accessible, and pandemic ready cell-based vaccine platforms to efficiently protect global populations from current and emerging diseases.